American Journal of Cancer Prevention
ISSN (Print): 2328-7314 ISSN (Online): 2328-7322 Website: http://www.sciepub.com/journal/ajcp Editor-in-chief: Nabil Abdel-Hamid
Open Access
Journal Browser
Go
American Journal of Cancer Prevention. 2015, 3(5), 86-88
DOI: 10.12691/ajcp-3-5-2
Open AccessResearch Article

Burkitt's Lymphoma of Right Maxillary Sinus: Case Report

Mehrdad Payandeh1, Edris Sadeghi2, 3, , Masoud Sadeghi2, 3 and Seyed-Hamid Madani4

1Department of Hematology and Medical Oncology, Kermanshah University of Medical Sciences, Kermanshah, Iran

2Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran

3Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

4Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

Pub. Date: October 07, 2015
(This article belongs to the Special Issue Advances in Non-Hodgkin Lymphomas)

Cite this paper:
Mehrdad Payandeh, Edris Sadeghi, Masoud Sadeghi and Seyed-Hamid Madani. Burkitt's Lymphoma of Right Maxillary Sinus: Case Report. American Journal of Cancer Prevention. 2015; 3(5):86-88. doi: 10.12691/ajcp-3-5-2

Abstract

Introduction: Burkitt’s lymphoma (BL) is an endemic malignant neoplasm with a mandibular localisation, first described, in 1958, in African children. In paranasal BL, maxillary sinus is most commonly involved and spheno-ethmoidal sinuses are less commonly involved. The aim of this study, we describe here a rare case of BL in the right maxillary sinus. Case Report: A 23-year-old female presented with a history of right nasal obstruction after pregnancy. In maxillary CT scan a hetrogenous large solid mass showed in the right maxillary sinus which expands this sinus and extends into the right nasal cavity and right ethmoid. She underwent surgical biopsy. In pathology of right maxillary sinus mass biopsy consistent with high grad diffuse small non cleaved NHL. She treated with combination chemotherapy regimen of CODOX-MVAC with triple intrathecal four courses suggested for her. Then she treated with maintenance therapy with thioguanin and MTX and now she is alive for 3 years after last treatment without any new drug and off all treatment and only is in follow up. Conclusion: BL in the right maxillary sinus is very rare but we will have a more successful treatment if it is diagnosed early.

Keywords:
BL CODOX-MVAC intrathecal maxillary sinus

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 5

References:

[1]  Burkitt D. Sarcoma involving the jaws in African children. Br J Surg. 1958. 46 (197): 218-23.
 
[2]  Mead GM, Sydes MR, Walewski J, Grigg A, Hatton CS, Norbert P, et al. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol. 2002. 13 (8): 1264-74.
 
[3]  Nikgoo A, Mirafshariyeh SA, Kazeminajad B, Eshkevari PS, Fatemitabar SA. Burkitt’s lymphoma of maxillary sinuses: review of literature and report of bilateral case. J Oral Maxillofac Surg. 2009. 67 (8): 1755-63.
 
[4]  Azarpira N, Ashraf MJ, Monabati A, Makarempour A, Khademi B, Hakimzadeh A, et al. Primary Lymphoma of Nasal Cavity and Paranasal Sinuses. Labe Mdicine. 2012. 43 (6): 294-99.
 
[5]  Lee DH, Yu MS, Lee BJ. Primary Burkitt's Lymphoma in the Nasal Cavity and Paranasal Sinuses. Clin Exp Otorhinolaryngol. 2013. 6 (3): 184-6.
 
[6]  Davidson KL, Devaney MB, Tighe JE, Rogers SY, Dunlop DJ, Mackie MJ, et al. A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study. Haematologica. 2003. 88 (12): 1366-71.
 
[7]  Hoelzer D, Walewski J, Döhner H, Viardot A, Hiddemann W, SpiekermannK, et al. Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood. 2014. 124 (26): 3870-79.